Pfizer Inc (PFE)

$26.79 -0.21 (-0.78%)
Market Cap 153.53B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.26
Forward PE 8.94
Profit Margin 12.42%
Debt to Equity Ratio 0.75
Volume 34,764,200
Avg Vol 37,806,320
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 42%
Beta 0.43
Analysts Sell
Price Target $29.02

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
LiveCommander
LiveCommander Apr. 28 at 12:48 AM
Iran reportedly down to 12-22 days of unused crude storage capacity 🏭. This is a critical inflection: forced production cuts loom, tightening seaborne supply at a moment OECD inventories already sit below 5-yr averages. Valuation remains compelling for integrated majors with FCF yield north of 8%. $XOM, $CVX, $PFE supply chain exposure warrants monitoring as crack spreads widen.
0 · Reply
LiveCommander
LiveCommander Apr. 28 at 12:21 AM
Iran reportedly down to 12-22 days of unused crude storage capacity 🏭. This is a critical inflection: forced production cuts loom, tightening seaborne supply at a moment OECD inventories already sit below 5-yr averages. Valuation remains compelling for integrated majors with FCF yield north of 8%. $XOM, $CVX, $PFE supply chain exposure warrants monitoring as crack spreads widen.
0 · Reply
ScamHedgefunds
ScamHedgefunds Apr. 27 at 11:42 PM
$PFE very bullish
1 · Reply
_Crim_Jamer_
_Crim_Jamer_ Apr. 27 at 11:11 PM
$PFE how long has it been 27?
1 · Reply
LiveCommander
LiveCommander Apr. 27 at 10:51 PM
Semis trading at ~60x P/E is a flashing yellow light 🏛️. The sector multiple has decoupled from historical norms, pricing in flawless AI capex execution and zero cyclical air-pockets. Names like $AVGO and $AMAT carry the narrative weight here. Valuation context matters: FCF yield compression at this level historically precedes mean reversion. Rotation into defensive cash-flow compounders like $PFE or $COST looks increasingly rational as risk-reward skews unfavorably.
0 · Reply
LiveCommander
LiveCommander Apr. 27 at 10:37 PM
S&P 500 cap-weighted printed a fresh ATH while the equal-weight gauge lagged meaningfully. The same divergence flashed in Jan 2025 and preceded a sharp mean-reversion. Mega-cap concentration is masking deteriorating breadth across $XLF and $XLI constituents. 🏛️ Valuation dispersion is now extreme: top decile trades at premium multiples while broader FCF yields in names like $PFE remain compelling. Watch for rotation, not collapse.
0 · Reply
FillSniper42
FillSniper42 Apr. 27 at 10:18 PM
POLA stock is bottomed out and has 5X potential (only trading at $6M valuation) - NO dilution - Potential $10 buyout coming - The department of defense described their product as the most advanced generator in production. - They supply devices to Raytheon ($233B market cap) + Lockhead Martin ($120B MC) $MU $F $PFE $IREN $CIFR watch these too
1 · Reply
_AceZerolag
_AceZerolag Apr. 27 at 9:57 PM
$PG $SNAP $PFE $AOSL pp
0 · Reply
MAUNGNYAN80
MAUNGNYAN80 Apr. 27 at 9:13 PM
$PFE do we need another COVID to move this shittt up ? Damn can’t even hold 27
1 · Reply
LiveCommander
LiveCommander Apr. 27 at 9:10 PM
Fundstrat's Tom Lee reiterating S&P 7,700 trajectory underscores conviction that the AI capex cycle and margin expansion remain intact. Operating leverage in defensive cash compounders like $COST and $PFE supports the secular bid 🏛️. Valuation isn't cheap, but FCF yield on quality names still offers asymmetric upside if disinflation persists and the Fed pivots dovish into 2026.
0 · Reply
Latest News on PFE
Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

Apr 24, 2026, 8:36 AM EDT - 3 days ago

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

BMY

Pfizer Transcript: AGM 2026

Apr 23, 2026, 9:00 AM EDT - 4 days ago

Pfizer Transcript: AGM 2026

Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 4:45 PM EDT - 5 days ago

Pfizer Declares Second-Quarter 2026 Dividend

Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 22, 2026, 5:18 AM EDT - 5 days ago

Pfizer GLP-1 weight loss drug available for pre-order in China

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Apr 21, 2026, 11:51 AM EDT - 6 days ago

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

Apr 20, 2026, 3:05 PM EDT - 7 days ago

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Apr 20, 2026, 6:45 AM EDT - 7 days ago

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

The Big 3: PFE, V, SYF

Apr 16, 2026, 1:01 PM EDT - 11 days ago

The Big 3: PFE, V, SYF

SYF V

Big Pharma Is Turning to China for the Newest Drug Ideas

Apr 10, 2026, 11:00 PM EDT - 16 days ago

Big Pharma Is Turning to China for the Newest Drug Ideas

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Apr 9, 2026, 10:00 AM EDT - 18 days ago

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Why Is Pfizer Stock Dropping Tuesday?

Apr 7, 2026, 1:54 PM EDT - 20 days ago

Why Is Pfizer Stock Dropping Tuesday?

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Apr 2, 2026, 11:14 AM EDT - 25 days ago

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

NVO LLY

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Apr 1, 2026, 11:39 AM EDT - 26 days ago

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

BNTX

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Apr 1, 2026, 10:13 AM EDT - 26 days ago

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

Mar 30, 2026, 10:44 AM EDT - 4 weeks ago

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

GSK LLY NVO PPH

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Mar 24, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

Mar 23, 2026, 12:46 PM EDT - 5 weeks ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

VALN

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

Mar 23, 2026, 10:35 AM EDT - 5 weeks ago

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

VALN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Mar 23, 2026, 9:36 AM EDT - 5 weeks ago

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

VALN

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Mar 23, 2026, 7:07 AM EDT - 5 weeks ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

VALN

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

Mar 23, 2026, 7:02 AM EDT - 5 weeks ago

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

VALN

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Mar 23, 2026, 6:47 AM EDT - 5 weeks ago

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

VALN

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Mar 23, 2026, 6:45 AM EDT - 5 weeks ago

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

VALN

5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 5 weeks ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Mar 20, 2026, 4:30 PM EDT - 5 weeks ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Mar 19, 2026, 6:45 AM EDT - 5 weeks ago

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 5 weeks ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 7:49 AM EDT - 5 weeks ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 17, 2026, 6:45 AM EDT - 5 weeks ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 7 weeks ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 9, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 7 weeks ago

China approves Pfizer GLP-1 drug for weight management

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Mar 5, 2026, 4:48 PM EST - 7 weeks ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Mar 4, 2026, 8:55 AM EST - 7 weeks ago

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

SMWB

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

Mar 3, 2026, 8:10 AM EST - 7 weeks ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

PRGO XRAY

Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 2 months ago

Pfizer CEO flags issues with FDA's vaccine leadership

Pfizer Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 10:30 AM EST - 2 months ago

Pfizer Transcript: TD Cowen 46th Annual Health Care Conference

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

Feb 27, 2026, 10:00 AM EST - 2 months ago

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Feb 24, 2026, 2:29 PM EST - 2 months ago

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 2 months ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Pfizer in diabetes drug deal with Sciwind Biosciences

Feb 23, 2026, 10:26 PM EST - 2 months ago

Pfizer in diabetes drug deal with Sciwind Biosciences

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

Feb 23, 2026, 3:15 PM EST - 2 months ago

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

MRK MRNA

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Feb 23, 2026, 10:00 AM EST - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 2 months ago

Is There 25% Downside For Pfizer Stock?

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Feb 17, 2026, 6:45 AM EST - 2 months ago

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Prices, pipelines and patent cliffs: Inside pharma's big reset

Feb 13, 2026, 6:13 AM EST - 2 months ago

Prices, pipelines and patent cliffs: Inside pharma's big reset

AMGN LLY NVO

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 2 months ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ABT ADBE AMGN AVGO BAC BK

Is Pfizer Stock Now A Value Trap?

Feb 11, 2026, 8:56 AM EST - 2 months ago

Is Pfizer Stock Now A Value Trap?

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Feb 10, 2026, 3:20 PM EST - 2 months ago

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Feb 6, 2026, 2:55 PM EST - 2 months ago

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Feb 6, 2026, 6:45 AM EST - 2 months ago

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Feb 5, 2026, 7:09 PM EST - 2 months ago

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Pfizer Earnings Call Transcript: Q4 2025

Feb 3, 2026, 10:00 AM EST - 2 months ago

Pfizer Earnings Call Transcript: Q4 2025

Pfizer Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:45 PM EST - 3 months ago

Pfizer Transcript: 44th Annual J.P. Morgan Healthcare Conference

Pfizer Transcript: Guidance

Dec 16, 2025, 8:00 AM EST - 4 months ago

Pfizer Transcript: Guidance

Pfizer Transcript: Jefferies London Healthcare Conference 2025

Nov 19, 2025, 4:00 AM EST - 5 months ago

Pfizer Transcript: Jefferies London Healthcare Conference 2025

Pfizer Transcript: Status Update

Nov 10, 2025, 8:30 AM EST - 6 months ago

Pfizer Transcript: Status Update

Pfizer Earnings Call Transcript: Q3 2025

Nov 4, 2025, 10:00 AM EST - 6 months ago

Pfizer Earnings Call Transcript: Q3 2025

Pfizer Transcript: M&A Announcement

Sep 22, 2025, 8:00 AM EDT - 7 months ago

Pfizer Transcript: M&A Announcement

Pfizer Earnings Call Transcript: Q2 2025

Aug 5, 2025, 10:00 AM EDT - 9 months ago

Pfizer Earnings Call Transcript: Q2 2025

Pfizer Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 9, 2025, 8:00 AM EDT - 11 months ago

Pfizer Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Pfizer Earnings Call Transcript: Q1 2025

Apr 29, 2025, 10:00 AM EDT - 1 year ago

Pfizer Earnings Call Transcript: Q1 2025

Pfizer Transcript: AGM 2025

Apr 24, 2025, 9:00 AM EDT - 1 year ago

Pfizer Transcript: AGM 2025

Pfizer Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 3, 2025, 10:30 AM EST - 1 year ago

Pfizer Transcript: TD Cowen 45th Annual Healthcare Conference

Pfizer Transcript: Status Update

Feb 27, 2025, 10:00 AM EST - 1 year ago

Pfizer Transcript: Status Update

Pfizer Earnings Call Transcript: Q4 2024

Feb 4, 2025, 10:30 AM EST - 1 year ago

Pfizer Earnings Call Transcript: Q4 2024

Pfizer Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 13, 2025, 12:45 PM EST - 1 year ago

Pfizer Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Pfizer Transcript: Status Update

Dec 18, 2024, 10:00 AM EST - 1 year ago

Pfizer Transcript: Status Update

Pfizer Transcript: Guidance

Dec 17, 2024, 8:30 AM EST - 1 year ago

Pfizer Transcript: Guidance

Pfizer Transcript: Jefferies London Healthcare Conference 2024

Nov 20, 2024, 4:00 AM EST - 1 year ago

Pfizer Transcript: Jefferies London Healthcare Conference 2024

Pfizer Transcript: UBS Global Healthcare Conference 2024

Nov 13, 2024, 3:30 PM EST - 1 year ago

Pfizer Transcript: UBS Global Healthcare Conference 2024

Pfizer Earnings Call Transcript: Q3 2024

Oct 29, 2024, 10:00 AM EDT - 1 year ago

Pfizer Earnings Call Transcript: Q3 2024

Pfizer Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Sep 4, 2024, 8:30 AM EDT - 1 year ago

Pfizer Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Pfizer Earnings Call Transcript: Q2 2024

Jul 30, 2024, 10:30 AM EDT - 1 year ago

Pfizer Earnings Call Transcript: Q2 2024

Pfizer Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

Jun 10, 2024, 11:20 AM EDT - 2 years ago

Pfizer Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

Pfizer Earnings Call Transcript: Q1 2024

May 1, 2024, 10:00 AM EDT - 2 years ago

Pfizer Earnings Call Transcript: Q1 2024

Pfizer Transcript: AGM 2024

Apr 25, 2024, 9:00 AM EDT - 2 years ago

Pfizer Transcript: AGM 2024

Pfizer Transcript: Leerink Partners Global Biopharma Conference 2024

Mar 12, 2024, 8:00 AM EDT - 2 years ago

Pfizer Transcript: Leerink Partners Global Biopharma Conference 2024

Pfizer Transcript: TD Cowen 44th Annual Health Care Conference 2024

Mar 4, 2024, 11:10 AM EST - 2 years ago

Pfizer Transcript: TD Cowen 44th Annual Health Care Conference 2024

Pfizer Transcript: Oncology Innovation Day

Feb 29, 2024, 1:00 PM EST - 2 years ago

Pfizer Transcript: Oncology Innovation Day

Pfizer Earnings Call Transcript: Q4 2023

Jan 30, 2024, 10:00 AM EST - 2 years ago

Pfizer Earnings Call Transcript: Q4 2023

Pfizer Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Jan 8, 2024, 6:00 PM EST - 2 years ago

Pfizer Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Pfizer Transcript: Investor Update

Dec 13, 2023, 8:30 AM EST - 2 years ago

Pfizer Transcript: Investor Update

Pfizer Transcript: The 6th Annual Evercore ISI HealthCONx Conference

Nov 28, 2023, 10:50 AM EST - 2 years ago

Pfizer Transcript: The 6th Annual Evercore ISI HealthCONx Conference

Pfizer Earnings Call Transcript: Q3 2023

Oct 31, 2023, 10:00 AM EDT - 2 years ago

Pfizer Earnings Call Transcript: Q3 2023

Pfizer Transcript: Investor Update

Oct 16, 2023, 8:00 AM EDT - 2 years ago

Pfizer Transcript: Investor Update

Pfizer Transcript: JP Morgan 14th Annual U.S. All Stars Conference

Sep 18, 2023, 6:00 AM EDT - 2 years ago

Pfizer Transcript: JP Morgan 14th Annual U.S. All Stars Conference

Pfizer Transcript: Morgan Stanley 21st Annual Global Healthcare Conference 2023

Sep 11, 2023, 12:15 PM EDT - 2 years ago

Pfizer Transcript: Morgan Stanley 21st Annual Global Healthcare Conference 2023

Pfizer Transcript: Citi’s 18th Annual BioPharma Conference

Sep 7, 2023, 10:30 AM EDT - 2 years ago

Pfizer Transcript: Citi’s 18th Annual BioPharma Conference

Pfizer Transcript: Wells Fargo Securities Healthcare Conference 2023

Sep 6, 2023, 12:45 PM EDT - 2 years ago

Pfizer Transcript: Wells Fargo Securities Healthcare Conference 2023

Pfizer Earnings Call Transcript: Q2 2023

Aug 1, 2023, 10:00 AM EDT - 2 years ago

Pfizer Earnings Call Transcript: Q2 2023

Pfizer Earnings Call Transcript: Q1 2023

May 2, 2023, 10:00 AM EDT - 3 years ago

Pfizer Earnings Call Transcript: Q1 2023

Pfizer Transcript: M&A Announcement

Mar 13, 2023, 8:00 AM EDT - 3 years ago

Pfizer Transcript: M&A Announcement

Pfizer Transcript: Cowen Health Care Conference

Mar 7, 2023, 10:30 AM EST - 3 years ago

Pfizer Transcript: Cowen Health Care Conference

Pfizer Transcript: SVB Securities Global Biopharma Conference

Feb 16, 2023, 10:00 AM EST - 3 years ago

Pfizer Transcript: SVB Securities Global Biopharma Conference

Pfizer Earnings Call Transcript: Q4 2022

Jan 31, 2023, 10:00 AM EST - 3 years ago

Pfizer Earnings Call Transcript: Q4 2022

Pfizer Transcript: JPMorgan Healthcare Conference

Jan 9, 2023, 6:00 PM EST - 3 years ago

Pfizer Transcript: JPMorgan Healthcare Conference

Pfizer Earnings Call Transcript: Q3 2022

Nov 1, 2022, 10:00 AM EDT - 3 years ago

Pfizer Earnings Call Transcript: Q3 2022

Pfizer Transcript: Status Update

Oct 20, 2022, 6:48 AM EDT - 3 years ago

Pfizer Transcript: Status Update

Pfizer Transcript: Fireside Chat

Sep 26, 2022, 4:32 AM EDT - 3 years ago

Pfizer Transcript: Fireside Chat

Pfizer Transcript: Status Update

Sep 21, 2022, 8:00 AM EDT - 3 years ago

Pfizer Transcript: Status Update

Pfizer Earnings Call Transcript: Q2 2022

Jul 27, 2022, 8:27 PM EDT - 4 years ago

Pfizer Earnings Call Transcript: Q2 2022

Pfizer Transcript: M&A Announcement

May 10, 2022, 7:11 AM EDT - 4 years ago

Pfizer Transcript: M&A Announcement

Pfizer Earnings Call Transcript: Q1 2022

May 3, 2022, 6:52 AM EDT - 4 years ago

Pfizer Earnings Call Transcript: Q1 2022

Pfizer Earnings Call Transcript: Q4 2021

Feb 8, 2022, 4:39 AM EST - 4 years ago

Pfizer Earnings Call Transcript: Q4 2021

Pfizer Transcript: Investor Call

Dec 16, 2021, 7:00 PM EST - 4 years ago

Pfizer Transcript: Investor Call

Pfizer Transcript: M&A Announcement

Dec 12, 2021, 7:00 PM EST - 4 years ago

Pfizer Transcript: M&A Announcement

Pfizer Earnings Call Transcript: Q3 2021

Nov 1, 2021, 8:00 PM EDT - 4 years ago

Pfizer Earnings Call Transcript: Q3 2021

Pfizer Earnings Call Transcript: Q2 2021

Jul 28, 2021, 2:22 AM EDT - 5 years ago

Pfizer Earnings Call Transcript: Q2 2021

Pfizer Earnings Call Transcript: Q1 2021

May 4, 2021, 10:05 AM EDT - 5 years ago

Pfizer Earnings Call Transcript: Q1 2021

Pfizer Transcript: AGM 2021

Apr 21, 2021, 8:25 PM EDT - 5 years ago

Pfizer Transcript: AGM 2021

Pfizer Transcript: Investor & Analyst Day 2021

Apr 8, 2021, 8:37 PM EDT - 5 years ago

Pfizer Transcript: Investor & Analyst Day 2021

Pfizer Earnings Call Transcript: Q4 2020

Feb 1, 2021, 8:47 PM EST - 5 years ago

Pfizer Earnings Call Transcript: Q4 2020

Pfizer Earnings Call Transcript: Q3 2020

Oct 26, 2020, 10:00 PM EDT - 5 years ago

Pfizer Earnings Call Transcript: Q3 2020

Pfizer Transcript: Investor Day Part 2 2020

Sep 14, 2020, 9:10 PM EDT - 6 years ago

Pfizer Transcript: Investor Day Part 2 2020

Pfizer Transcript: Investor Day Part 1 2020

Sep 13, 2020, 9:05 PM EDT - 6 years ago

Pfizer Transcript: Investor Day Part 1 2020

Pfizer Earnings Call Transcript: Q2 2020

Jul 27, 2020, 9:17 PM EDT - 6 years ago

Pfizer Earnings Call Transcript: Q2 2020

Pfizer Transcript: Analyst & Investor Call

Jun 30, 2020, 9:21 PM EDT - 6 years ago

Pfizer Transcript: Analyst & Investor Call

Pfizer Transcript: Analyst & Investor Call

Jun 17, 2020, 9:38 PM EDT - 6 years ago

Pfizer Transcript: Analyst & Investor Call

Pfizer Transcript: Analyst & Investor Call

May 14, 2020, 9:48 PM EDT - 6 years ago

Pfizer Transcript: Analyst & Investor Call

Pfizer Earnings Call Transcript: Q1 2020

Apr 27, 2020, 9:55 PM EDT - 6 years ago

Pfizer Earnings Call Transcript: Q1 2020

Pfizer Transcript: AGM 2020

Apr 22, 2020, 10:06 PM EDT - 6 years ago

Pfizer Transcript: AGM 2020

Pfizer Earnings Call Transcript: Q4 2019

Jan 27, 2020, 10:09 PM EST - 6 years ago

Pfizer Earnings Call Transcript: Q4 2019

Pfizer Earnings Call Transcript: Q3 2019

Oct 28, 2019, 11:16 PM EDT - 7 years ago

Pfizer Earnings Call Transcript: Q3 2019

Pfizer Earnings Call Transcript: Q2 2019

Jul 28, 2019, 10:20 PM EDT - 7 years ago

Pfizer Earnings Call Transcript: Q2 2019

Pfizer Transcript: M&A Announcement

Jun 16, 2019, 10:23 PM EDT - 7 years ago

Pfizer Transcript: M&A Announcement

Pfizer Earnings Call Transcript: Q1 2019

Apr 29, 2019, 10:27 PM EDT - 7 years ago

Pfizer Earnings Call Transcript: Q1 2019

Pfizer Transcript: Analyst Day 2019

Apr 24, 2019, 10:35 PM EDT - 7 years ago

Pfizer Transcript: Analyst Day 2019

Pfizer Earnings Call Transcript: Q4 2018

Jan 28, 2019, 10:41 PM EST - 7 years ago

Pfizer Earnings Call Transcript: Q4 2018

LiveCommander
LiveCommander Apr. 28 at 12:48 AM
Iran reportedly down to 12-22 days of unused crude storage capacity 🏭. This is a critical inflection: forced production cuts loom, tightening seaborne supply at a moment OECD inventories already sit below 5-yr averages. Valuation remains compelling for integrated majors with FCF yield north of 8%. $XOM, $CVX, $PFE supply chain exposure warrants monitoring as crack spreads widen.
0 · Reply
LiveCommander
LiveCommander Apr. 28 at 12:21 AM
Iran reportedly down to 12-22 days of unused crude storage capacity 🏭. This is a critical inflection: forced production cuts loom, tightening seaborne supply at a moment OECD inventories already sit below 5-yr averages. Valuation remains compelling for integrated majors with FCF yield north of 8%. $XOM, $CVX, $PFE supply chain exposure warrants monitoring as crack spreads widen.
0 · Reply
ScamHedgefunds
ScamHedgefunds Apr. 27 at 11:42 PM
$PFE very bullish
1 · Reply
_Crim_Jamer_
_Crim_Jamer_ Apr. 27 at 11:11 PM
$PFE how long has it been 27?
1 · Reply
LiveCommander
LiveCommander Apr. 27 at 10:51 PM
Semis trading at ~60x P/E is a flashing yellow light 🏛️. The sector multiple has decoupled from historical norms, pricing in flawless AI capex execution and zero cyclical air-pockets. Names like $AVGO and $AMAT carry the narrative weight here. Valuation context matters: FCF yield compression at this level historically precedes mean reversion. Rotation into defensive cash-flow compounders like $PFE or $COST looks increasingly rational as risk-reward skews unfavorably.
0 · Reply
LiveCommander
LiveCommander Apr. 27 at 10:37 PM
S&P 500 cap-weighted printed a fresh ATH while the equal-weight gauge lagged meaningfully. The same divergence flashed in Jan 2025 and preceded a sharp mean-reversion. Mega-cap concentration is masking deteriorating breadth across $XLF and $XLI constituents. 🏛️ Valuation dispersion is now extreme: top decile trades at premium multiples while broader FCF yields in names like $PFE remain compelling. Watch for rotation, not collapse.
0 · Reply
FillSniper42
FillSniper42 Apr. 27 at 10:18 PM
POLA stock is bottomed out and has 5X potential (only trading at $6M valuation) - NO dilution - Potential $10 buyout coming - The department of defense described their product as the most advanced generator in production. - They supply devices to Raytheon ($233B market cap) + Lockhead Martin ($120B MC) $MU $F $PFE $IREN $CIFR watch these too
1 · Reply
_AceZerolag
_AceZerolag Apr. 27 at 9:57 PM
$PG $SNAP $PFE $AOSL pp
0 · Reply
MAUNGNYAN80
MAUNGNYAN80 Apr. 27 at 9:13 PM
$PFE do we need another COVID to move this shittt up ? Damn can’t even hold 27
1 · Reply
LiveCommander
LiveCommander Apr. 27 at 9:10 PM
Fundstrat's Tom Lee reiterating S&P 7,700 trajectory underscores conviction that the AI capex cycle and margin expansion remain intact. Operating leverage in defensive cash compounders like $COST and $PFE supports the secular bid 🏛️. Valuation isn't cheap, but FCF yield on quality names still offers asymmetric upside if disinflation persists and the Fed pivots dovish into 2026.
0 · Reply
LiveCommander
LiveCommander Apr. 27 at 9:07 PM
The $250K $ETH.X thesis hinges on absolute network dominance—an unrealistic assumption given fragmented L2 economics and rotating capital into yield-bearing alternatives. Monetary premium narratives rarely survive contested moats. 🏛️ Valuation-wise, discounting such terminal values requires near-zero competitive erosion. Investors anchoring digital asset exposure should weigh FCF-generative names like $COST or $PFE against speculative compounding scenarios.
0 · Reply
AceZerolag
AceZerolag Apr. 27 at 8:35 PM
$PFE $RCAT $EOSE $AOSL ngcc
1 · Reply
MoonTargets
MoonTargets Apr. 27 at 8:02 PM
$INTC $PFE swing them
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 27 at 7:57 PM
$PFE it literally never changes
0 · Reply
nimii
nimii Apr. 27 at 7:26 PM
$PFE this goes up when nvidia crash
0 · Reply
Typecheck
Typecheck Apr. 27 at 5:44 PM
$PFE lot of people hates dividend apparently. Otherwise, how to explain the rapid sell before ex-dividend date?
1 · Reply
maq34
maq34 Apr. 27 at 5:19 PM
$ATRC $JNJ $MDT $HIMS $PFE https://www.marketbeat.com/instant-alerts/filing-oak-harvest-investment-services-makes-new-148-million-investment-in-atricure-inc-atrc-2026-04-18/ https://www.marketbeat.com/instant-alerts/filing-oak-harvest-investment-services-makes-new-148-million-investment-in-atricure-inc-atrc-2026-04-18/
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 27 at 5:15 PM
$PFE it’s so damn bad
1 · Reply
OptionsProOfficial
OptionsProOfficial Apr. 27 at 5:14 PM
$PFE options so far today have stayed relatively calm, with moderate put and call flows around defensive-strike levels, fitting a slow-moving healthcare profile rather than a high-volatility momentum trade. NFA
0 · Reply
LiveCommander
LiveCommander Apr. 27 at 4:49 PM
This isn’t just growth - NextNRG, Inc. is positioned inside a system constraint. $APLD $PFE $RGTI
0 · Reply
NRG8
NRG8 Apr. 27 at 4:18 PM
$ABBV $NVS $ABT $MRK $PFE .
0 · Reply
bearhunter429
bearhunter429 Apr. 27 at 4:07 PM
$PFE i am going to add this to my retirement account. 6.37% dividend on healthcare is too good to pass up.
0 · Reply